BOTHELL, Wash., April 1, 2008 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it signed a letter of intent to begin establishing Heartcentrix(R) ECG connectivity with the Misys MyWay(TM) electronic medical record (EMR) system from Misys Healthcare.
Misys Healthcare serves more than 100,000 physicians in 18,000 practice locations. "Misys MyWay integrates EMR, practice management, and claims management to offer a simple, affordable, complete solution for physicians and clinicians," Paul Edge, Vice President, Clinical Solutions for Misys Healthcare said. "With this agreement, thousands of our customers have the potential to access information from new or currently installed Burdick and Quinton electrocardiograph (ECG) devices, stress systems, and Holter devices while using our Misys MyWay EMR systems."
The HeartCentrix solution from Cardiac Science helps bring patient history, clinical charting, e-prescribing, lab orders, results, and patient follow-up information together into a single EMR application. "We designed HeartCentrix to streamline diagnostic cardiology workflow," said Greg Newman, senior marketing manager for Cardiac Science. "Ultimately, the patient benefits. With streamlined integration, physicians have easier access to information, faster results, and fewer chances for operator error, patients receive a higher standard of care."
Tony Titus, Cardiac Science vice president of marketing added, "The agreement with Misys Healthcare is another step in our goal to connect our diagnostic cardiology products seamlessly with all major EMR solution providers. We're very much looking forward to this partnership."
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
About Misys Healthcare Systems, LLC
Misys Healthcare -- part of the global application software and services company, Misys plc (FTSE: MSY.L) -- delivers integrated, comprehensive solutions that improve results for healthcare practitioners. Drawing on our decades of healthcare experience, our relationships with more than 100,000 healthcare professionals, and our commitment to customer success, we deliver innovative software and services that enable physicians, caregivers, and a connected healthcare community. Misys Healthcare: Experience, Solutions, Results. Contact us today; visit http://www.misyshealthcare.com.
Forward Looking Statements
This press release contains forward-looking statements. These
statements and their underlying assumptions involve a number of risks and
uncertainties and are not guarantees of future performance. These are
forward-looking statements for purposes of the safe harbor provisions under
the Private Securities Litigation Reform Act of 1995. The words "believe,"
"expect," "intend," anticipate," variations of such words, and similar
expressions identify forward-looking statements, but their absence does not
mean that the statement is not forward looking. Actual results may vary
significantly from the results expressed or implied in such statements.
Forward looking statements in this press release include those that infer
or imply that the revenue and profits of Cardiac Science may increase as a
result of the connectivity of its products with those of Misys, as well as
other risks that are more fully described in the Annual Report on Form 10-K
filed by Cardiac Science Corporation for the year ended December 31, 2006.
Cardiac Science Corporation undertakes no duty or obligation to update the
information provided herein.
Company Contact: Investor Contact: Media Contact:
Mike Matysik Jenifer Kirtland Christopher Gale
Cardiac Science Corporation EVC Group, Inc. EVC Group, Inc.
Sr. Vice President and CFO (415) 896-6820 (201) 646-5431
(425) 402-2009 (203) 570-4681
email@example.com CSCX - G
|SOURCE Cardiac Science Corporation|
Copyright©2008 PR Newswire.
All rights reserved